162 related articles for article (PubMed ID: 16385548)
1. Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis.
Karassa FB; Afeltra A; Ambrozic A; Chang DM; De Keyser F; Doria A; Galeazzi M; Hirohata S; Hoffman IE; Inanc M; Massardo L; Mathieu A; Mok CC; Morozzi G; Sanna G; Spindler AJ; Tzioufas AG; Yoshio T; Ioannidis JP
Arthritis Rheum; 2006 Jan; 54(1):312-24. PubMed ID: 16385548
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic value of anti-alpha-fodrin antibody testing for Sjögren's syndrome: a meta-analysis].
Huang QS; LE AP; Luo ZQ; Li JM; Wang WQ; Ju BH; Wan LG
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(42):2971-6. PubMed ID: 19080074
[TBL] [Abstract][Full Text] [Related]
3. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
[TBL] [Abstract][Full Text] [Related]
4. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus.
Yoshio T; Hirata D; Onda K; Nara H; Minota S
J Rheumatol; 2005 Jan; 32(1):34-9. PubMed ID: 15630721
[TBL] [Abstract][Full Text] [Related]
5. The role of measurement of serum autoantibodies in prediction of pediatric neuropsychiatric systemic lupus erythematosus.
Mostafa GA; Ibrahim DH; Shehab AA; Mohammed AK
J Neuroimmunol; 2010 Oct; 227(1-2):195-201. PubMed ID: 20724007
[TBL] [Abstract][Full Text] [Related]
6. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.
Sanna G; Bertolaccini ML; Cuadrado MJ; Laing H; Khamashta MA; Mathieu A; Hughes GR
J Rheumatol; 2003 May; 30(5):985-92. PubMed ID: 12734893
[TBL] [Abstract][Full Text] [Related]
7. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus.
Arinuma Y; Yanagida T; Hirohata S
Arthritis Rheum; 2008 Apr; 58(4):1130-5. PubMed ID: 18383393
[TBL] [Abstract][Full Text] [Related]
8. [Characteristic manifestations of neuropsychiatric systemic lupus erythematosus].
Liu Z; Chen L; Cui LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):509-12. PubMed ID: 16178450
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis.
Yin Y; Wu X; Shan G; Zhang X
Lupus; 2012 Sep; 21(10):1088-97. PubMed ID: 22777943
[TBL] [Abstract][Full Text] [Related]
10. Antibodies in patients with neuropsychiatric systemic lupus erythematosus.
Kimura A; Kanoh Y; Sakurai T; Koumura A; Yamada M; Hayashi Y; Tanaka Y; Hozumi I; Takemura M; Seishima M; Inuzuka T
Neurology; 2010 Apr; 74(17):1372-9. PubMed ID: 20421581
[TBL] [Abstract][Full Text] [Related]
11. Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus.
Haddouk S; Marzouk S; Jallouli M; Fourati H; Frigui M; Hmida YB; Koubaa F; Sellami W; Baklouti S; Hachicha J; Bahloul Z; Masmoudi H
Rheumatology (Oxford); 2009 Aug; 48(8):953-7. PubMed ID: 19502474
[TBL] [Abstract][Full Text] [Related]
12. Valvular heart disease is associated with nonfocal neuropsychiatric systemic lupus erythematosus.
Roldan CA; Gelgand EA; Qualls CR; Sibbitt WL
J Clin Rheumatol; 2006 Feb; 12(1):3-10. PubMed ID: 16484873
[TBL] [Abstract][Full Text] [Related]
13. Antineuronal antibodies and electroneurophysiological studies in pediatric patients with neuropsychiatric systemic lupus erythematosus.
Mostafa GA; Nazif HK; El-Shahawi HH; Abd El-Aziz MM; Hassan MA
Pediatr Allergy Immunol; 2009 Mar; 20(2):192-9. PubMed ID: 18422890
[TBL] [Abstract][Full Text] [Related]
14. Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus.
Steens SC; Bosma GP; Steup-Beekman GM; le Cessie S; Huizinga TW; van Buchem MA
Arthritis Res Ther; 2006; 8(2):R38. PubMed ID: 16469116
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE).
Hermosillo-Romo D; Brey RL
Best Pract Res Clin Rheumatol; 2002 Apr; 16(2):229-44. PubMed ID: 12041951
[TBL] [Abstract][Full Text] [Related]
16. Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India.
Seth G; Sundaresh A; Mariaselvam CM; Kumar G; Chengappa KG; Adarsh MB; Tamouza R; Negi VS
Lupus; 2020 Apr; 29(4):413-420. PubMed ID: 32106787
[TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus.
Ho RC; Thiaghu C; Ong H; Lu Y; Ho CS; Tam WW; Zhang MW
Autoimmun Rev; 2016 Feb; 15(2):124-38. PubMed ID: 26497108
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with anti-ribosomal P antibodies.
Nery FG; Borba EF; Viana VS; Hatch JP; Soares JC; Bonfá E; Neto FL
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):695-700. PubMed ID: 18077068
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to microtubule-associated protein-2 in the cerebrospinal fluid are a useful diagnostic biomarker for neuropsychiatric systemic lupus erythematosus.
Yamada Y; Nozawa K; Nakano S; Mitsuo Y; Hiruma K; Doe K; Sekigawa I; Yamanaka K; Takasaki Y
Mod Rheumatol; 2016 Jul; 26(4):562-8. PubMed ID: 26667376
[TBL] [Abstract][Full Text] [Related]
20. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
